User profiles for Daniel Heinrich

Daniel Heinrich

Professor of Marketing and Digital Media
Verified email at dfki.de
Cited by 2380

[HTML][HTML] Alpha emitter radium-223 and survival in metastatic prostate cancer

C Parker, S Nilsson, D Heinrich, SI Helle… - … England Journal of …, 2013 - Mass Medical Soc
Background Radium-223 dichloride (radium-223), an alpha emitter, selectively targets bone
metastases with alpha particles. We assessed the efficacy and safety of radium-223 as …

Consumer brand relationships research: A bibliometric citation meta-analysis

M Fetscherin, D Heinrich - Journal of Business Research, 2015 - Elsevier
This study examines how scholarly research on consumer brand relationships has evolved
over the last decades by conducting a bibliometric citation meta-analysis. The bibliography …

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3 …

O Sartor, R Coleman, S Nilsson, D Heinrich… - The Lancet …, 2014 - thelancet.com
Background Bone metastases frequently cause skeletal events in patients with metastatic
castration-resistant prostate cancer. Radium-223 dichloride (radium-223) selectively targets …

Brand authenticity: Towards a deeper understanding of its conceptualization and measurement

…, V Schoenmüller, D Schäfer, D Heinrich - Advances in consumer …, 2012 - papers.ssrn.com
In times of increasing uncertainty, authenticity is an essential human aspiration, making it a
key issue in contemporary marketing and a major factor for brand success. By conducting a …

[HTML][HTML] Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019

…, M Gleave, S Halabi, A Heidenreich, D Heinrich… - European urology, 2020 - Elsevier
Background Innovations in treatments, imaging, and molecular characterisation in advanced
prostate cancer have improved outcomes, but there are still many aspects of management …

Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial

…, AA Azad, J Carles, AP Fay, N Matsubara, D Heinrich… - The Lancet, 2023 - thelancet.com
Background Co-inhibition of poly(ADP-ribose) polymerase (PARP) and androgen receptor
activity might result in antitumour efficacy irrespective of alterations in DNA damage repair …

Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b …

…, S Gillessen, A Heidenreich, D Heinrich… - The Lancet …, 2016 - thelancet.com
Background In the previously reported ALSYMPCA trial in patients with castration-resistant
prostate cancer and symptomatic bone metastases, overall survival was significantly longer …

The effects of organic labels on global, local, and private brands: More hype than substance?

HH Bauer, D Heinrich, DB Schäfer - Journal of Business Research, 2013 - Elsevier
With an ever-expanding market for diversified health food products, marketers can formulate
a unique selling proposition by differentiating their brands using organic labels issued by an …

[HTML][HTML] Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of …

…, D George, M Gleave, G Gravis, S Halabi, D Heinrich… - European urology, 2023 - Elsevier
Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …

[PDF][PDF] How to create high emotional consumer-brand relationships? The causalities of brand passion

HH Bauer, D Heinrich, I Martin - 2007 Australian & New Zealand …, 2007 - researchgate.net
As emotional consumer-brand relationships have a high impact on consumer behaviour, brand
managers tend to create passionate brands, eg by using emotional advertising messages…